Generic · Oral solution
Acetaminophen / oxycodone 60 mg/mL / 2 mg/mL oral solution price what pharmacies pay, and what you should
There is no weekly pharmacy acquisition cost for acetaminophen / oxycodone 60 mg/ml / 2 mg/ml oral solution this week. The makers, package codes, recalls and label are below.
What people paid for acetaminophen / oxycodone 60 mg/ml / 2 mg/ml oral solution
What did your pharmacy charge? It takes 30 seconds, it's anonymous - and it shows everyone which pharmacies are fair.
Supply status: shortages & recalls
Recalls
A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.
Every manufacturer and package code
1 company sell acetaminophen / oxycodone 60 mg/ml / 2 mg/ml oral solution under 1 package code (NDC).
| Maker | Package codes | Per unit |
|---|---|---|
| FH2 Pharma LLC | 72887-648-12 | - |
All 1 package codes
A dash means no weekly price for that maker's packages. Which maker your pharmacy stocks usually doesn't change what you pay, but you can ask.
Other acetaminophen / oxycodone strengths and forms
| Strength and form | Per unit | Pharmacies pay | ||
|---|---|---|---|---|
| 65 mg/mL / 1 mg/mL oral solution | Not priced this week | |||
| 325 mg / 10 mg tablet | $0.2300 | $6.90 / 30 tablets | ||
| 325 mg / 2.5 mg tablet | $0.8394 | $25.18 / 30 tablets | ||
| 325 mg / 5 mg tablet | $0.1178 | $3.53 / 30 tablets | ||
| 325 mg / 7.5 mg tablet | $0.1828 | $5.48 / 30 tablets | ||
Official label & what changed
Oxycodone and Acetaminophen Tablets USP CII 5 mg*/325 mg, 7.5 mg*/325 mg and 10 mg*/325 mg Revised: JANUARY 2026
WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF OXYCODONE AND ACETAMINOPHEN TABLETS
Addiction, Abuse, and Misuse
Because the use of oxycodone and acetaminophen tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient's risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions (see WARNINGS).
Life-Threatening Respiratory Depression
Serious, life-threatening, or fatal respiratory depression may occur with use of oxycodone and acetaminophen tablets, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of oxycodone and acetaminophen tablets are essential (see WARNINGS).
Accidental Ingestion
Accidental ingestion of even one dose of oxycodone and acetaminophen tablets, especially by children, can result in a fatal overdose of oxycodone (see WARNINGS).
Risks From Concomitant Use with Benzodiazepines or Other CNS Depressants
Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of oxycodone and acetaminophen tablets and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate (see WARNINGS, PRECAUTIONS, Drug Interactions).
Neonatal Opioid Withdrawal Syndrome (NOWS)
Advise pregnant women using opioids for an extended period of time of the risk of Neonatal Opioid Withdrawal Syndrome, which may be life-threatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery (see WARNINGS).
Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS)
Healthcare providers are strongly encouraged to complete a REMS-compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription (see WARNINGS).
Cytochrome P450 3A4 Interaction
The concomitant use of oxycodone and acetaminophen tablets with all cytochrome P450 3A4 inhibitors may result in an increase in oxycodone plasma concentrations, which could increase or prolong adverse reactions and may cause potentially fatal respiratory depression. In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in an increase in oxycodone plasma concentration. Monitor patients receiving oxycodone and acetaminophen tablets and any CYP3A4 inhibitor or inducer (see CLINICAL PHARMACOLOGY, WARNINGS and PRECAUTIONS, Drug Interactions).
Hepatotoxicity
Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed 4000 mg per day, and often involve more than one acetaminophen-containing product.
We check this label every day. When it changes, the sections that changed appear here, old text beside new.
We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.
Questions about acetaminophen / oxycodone 60 mg/ml / 2 mg/ml oral solution
Who makes acetaminophen / oxycodone 60 mg/ml / 2 mg/ml oral solution?
1 company: FH2 Pharma LLC. See every package code.
Is acetaminophen / oxycodone in shortage?
No shortage is reported right now. We check every day.
Has acetaminophen / oxycodone been recalled?
6 recalls on record, 2 ongoing. Recalls name specific lots - check yours.
What does "pharmacies pay" mean?
It's the national average price retail pharmacies pay wholesalers and makers to buy the drug, from a weekly government survey of pharmacy invoices. It doesn't include the pharmacy's costs of filling a prescription, which is why the fair price adds a margin and a dispensing fee. How we work it out.
Talk about acetaminophen / oxycodone 60 mg/ml / 2 mg/ml oral solution
No comments yet. Questions, tips, what worked for you - start the conversation.